The approval letter is the first to cover a meat-replacing mycoprotein strain outside of the Fusarium genus and the first to include an USDA evaluation of mycoprotein as a meat enhancer.
The startup has LOIs and offtake agreements from joint development agreement partners for 33 tons of dry mycoprotein per month (99 tons when hydrated), claims CEO Paul Shapiro.
While this is not the optimal time to raise capital, the fact that Enifer’s PEKILO strain has been grown at industrial scale before has de-risked the enterprise for investors, says its CEO.
Maia Farms’ fungi-fueled biomass fermentation platform, which uses mycelium from edible mushroom varieties, can deliver “significantly higher yields” than Fusarium-type products, claims the startup.
The Maia Farms & Ecoation growing system for mycelium and fresh produce can make 700kg of food a year in a device the size of a wardrobe.
“My view of the market is that we had a bit of a hype cycle, but the underlying trends [driving alt protein] are there,” says ENOUGH CEO Jim Laird.
A spinoff from VTT in Finland, Enifer is targeting human food, petfood, and aquaculture markets with its mycoprotein, produced from a fungal strain first commercialized in the 1970s.
A month into his new role as CEO at fungi-fueled startup MycoTechnology, Dr. Mike Leonard caught up with AgFunderNews to talk about his new role.
Alt meat startup Meati Foods has embarked on its second round of layoffs in three months but says its confidence in its long-term prospects remains ‘unwavering.’
Alt protein startup ENOUGH has raised $43.6 m in a series C round led by World Fund CPT Capital to expand its mycoprotein business.
Aqua Cultured Foods has raised $5.5 million in a seed round led by Stray Dog Capital to expand its fermentation-based production platform for high-protein whole cuts of fungi-based seafood.
F&A Next 2022 is taking place in Wageningen, the Netherlands, and online next week. AFN readers can get a discount on last-minute tickets.
The Mushroom Meat Co.’s CEO explains the ups and downs of starting (and growing) a clean-label protein company in today’s crowded industry.
The Swedish biotech company will take its mycelium-based protein ingredient from prototype stage to commercial-scale production by 2023.
The Myco-Protein Innovation Call is focused on scaling the use of fungi as a protein source.
It’s building a “first of its kind” protein factory in the Netherlands with the aim of producing 1 million tonnes of mycoprotein annually by 2032.
Monde Nissin raised just over $1 billion in its Philippines IPO – and is earmarking much of it for expansion in the US.
It will be the Philippines’ biggest-ever IPO – and it’s being driven by demand for alt-protein and instant noodles.
